VIE/XRAY (VIE/XRAY)

Vienna Stock Exchange: VIE/XRAY · EUR

€8.70

+0.27 (+3.2%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	3.2B
Net income (ttm)	-477.9M
EPS (ttm)	-€2.44
P/E (forward)	6.7x
Dividend	€0.14 (1.56%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.2B
Net income (ttm): -477.9M
EPS (ttm): -€2.44
P/E (forward): 6.7x
Market cap: 1.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E6.7

P25 14.3P50 18.7P75 25.4

Trailing P/En/a

P25 20.4P50 26.7P75 39.7

ROE-33

P25 4.8P50 10.6P75 20.1

ROIC5.1

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/XRAY indicators

Market & fundamental data

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-11-05
Employees	14,000
Employees change	-1,000
Employees growth	-6.67%
Enterprise value	EUR 3.6B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1877
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	US24906P1093
Last earnings date	2026-08-06
Last refreshed	2026-10-30
Market cap	EUR 1.7B
Next earnings date	2026-11-05
Price	EUR 8.70
Price currency	EUR
Sector	Healthcare
SIC code	3843
Stock price date	2026-10-29
Symbol	vie/XRAY
Website	https://www.dentsplysirona.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-28.08%
EV/EBIT	22.62x
EV/EBITDA	6.59x
EV/FCF	28.65x
EV/Sales	1.1x
FCF / EV yield	3.49%
FCF yield	7.29%
Forward P/E	6.71x
P/(FCF - SBC) ratio	17.5x
P/(OCF - SBC) ratio	6.81x
P/B ratio	1.45x
P/FCF ratio	13.71x
P/OCF ratio	6.15x
P/S ratio	0.54x
Price/EBITDA ratio	3.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.86%
EBITDA margin	14.44%
FCF margin	3.85%
Gross margin	49.52%
Operating margin	4.86%
Pretax margin	-9.53%
Profit margin	-14.99%
Profit per employee	EUR -34,137
Profitable quarters	1
Revenue per employee	EUR 227,766
ROA	1.96%
ROA (5Y)	2.82%
ROCE	4.4%
ROE	-33.03%
ROE (5Y)	-17.64%
ROIC	5.12%
ROIC (5Y)	5.86%
SBC / revenue	0.85%
Tax / revenue	5.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
FCF growth	3.62%
FCF growth (Q)	243.75%
FCF growth 3Y	-10.28%
FCF growth 5Y	-25.76%
Gross profit growth	-5.35%
Gross profit growth (Q)	0.61%
Gross profit growth 3Y	-4.91%
Gross profit growth 5Y	-4.15%
Net income growth quarters	1
Net income growth years	1
OCF growth	12.72%
OCF growth (Q)	106.25%
OCF growth (QoQ)	147.5%
OCF growth 10Y	-3.89%
OCF growth 3Y	-1.52%
OCF growth 5Y	-15.67%
Operating income growth	-37.23%
Operating income growth (Q)	-23.85%
Operating income growth 3Y	-13.97%
Operating income growth 5Y	-22.13%
Revenue growth	-0.76%
Revenue growth (Q)	-4.06%
Revenue growth (QoQ)	2.05%
Revenue growth 10Y	1.58%
Revenue growth 3Y	-2.55%
Revenue growth 5Y	-2.15%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -154.1M
Depreciation and amortization	EUR 311.7M
EBIT	EUR 154.9M
EBITDA	EUR 460.4M
EPS	EUR -2.44
Financing cash flow	EUR -232M
Free cash flow	EUR 125.2M
Free cash flow minus SBC	EUR 98M
Gross profit	EUR 1.6B
Income taxes	EUR 175.1M
Investing cash flow	EUR -151.4M
Net borrowing	EUR -130.4M
Net cash flow	EUR -105M
Net income	EUR -477.9M
Operating cash flow minus SBC	EUR 252.1M
Operating income	EUR 154.9M
Revenue	EUR 3.2B
Stock-based compensation	EUR 27.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.96
Book value per share	EUR 5.94
Debt / EBITDA	3.83
Debt / equity	1.72
Debt / FCF	16.27
Goodwill	EUR 1B
Interest coverage	1.7
Long-term assets	EUR 2.8B
Long-term liabilities	EUR 2.3B
Net cash (debt)	EUR -1.8B
Net cash / market cap	-106.51%
Net debt / EBITDA	3.97
Net debt / equity	1.55
Net debt / FCF	14.6
Piotroski F-Score	5
Property, plant and equipment	EUR 869.9M
Shareholders' equity	EUR 1.2B
Tangible book value	EUR -575.1M
Tangible book value per share	EUR -2.89
Total assets	EUR 4.6B
Total cash	EUR 209.2M
Total debt	EUR 2B
Total liabilities	EUR 3.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.65
Current assets	EUR 1.7B
Current liabilities	EUR 1.1B
Current ratio	1.63
Inventory turnover	2.74
Net working capital	EUR 644.2M
Quick ratio	0.72
Working capital	EUR 650.3M
Working capital turnover	4.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.08%
Dividend growth	-6.09%
Dividend growth (3Y)	5.22%
Dividend growth (5Y)	9.85%
Dividend growth years	0
Dividend payment date	2026-01-09
Dividend payment years	10
Dividend per share	EUR 0.14
Dividend yield	1.56%
Ex-dividend date	2025-12-26
Last dividend	EUR 0.14
Shareholder yield	1.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 9.49
1D price change	3.18%
1M price change	9.8%
1M total return	9.8%
1W price change	2.89%
1W total return	2.89%
1Y price change	-22.56%
1Y return CAGR	-21.47%
1Y total return	-21.46%
20-day SMA	EUR 7.88
200-day SMA	EUR 9.80
3M price change	-25.36%
3M total return	-25.36%
3Y price change	-70.08%
3Y return CAGR	-31.37%
3Y total return	-67.68%
50-day SMA	EUR 8.56
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 12.47
52-week high date	2026-07-30
52-week low	EUR 7.51
52-week low date	2026-10-20
5Y price change	-82.28%
5Y return CAGR	-27.76%
5Y total return	-80.32%
6M price change	-13.9%
6M total return	-13.9%
All-time high	EUR 57.63
All-time high date	2017-11-30
All-time low	EUR 7.51
All-time low date	2026-10-20
Average true range (ATR)	EUR 0.23
Average volume	8.6
Change from 52-week high	-30.24%
Change from 52-week low	15.73%
Change from all-time high	-84.91%
Change from all-time low	15.73%
Change from open	2.26%
Day's gap	0.9%
High price	EUR 8.70
Low price	EUR 8.44
Monthly RSI	34.92
Open price	EUR 8.50
Position in 52-week range	100%
Previous close	EUR 8.43
Price vs 150-day SMA	-8.4%
Price vs 20-day SMA	10.36%
Price vs 200-day SMA	-11.27%
Price vs 50-day SMA	1.55%
Relative volume	2.23
RSI	60.38
Sharpe ratio	-0.4
Sharpe ratio (3Y)	-0.83
Sharpe ratio (5Y)	-0.79
Sortino ratio	-0.45
Sortino ratio (3Y)	-0.98
Sortino ratio (5Y)	-0.91
Weekly RSI	44.83
YTD price change	-8.96%
YTD total return	-8.96%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	187.9M
Shares change (QoQ)	0.3%
Shares change (YoY)	0.08%
Shares held by insiders	0.49%
Shares held by institutions	109.72%
Short ratio	6.5 days

Deeper analysis on VIE/XRAY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/XRAY report

Is a complete VIE/XRAY research report available?

No complete published report is available for vie/XRAY (VIE/XRAY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/XRAY (VIE/XRAY)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/XRAY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/XRAY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/XRAY

Frequently asked questions